StockStory flags Lennar as risky, PTC and AbbVie as promising S&P 500 stocks

Industry
โดย StockStory·Read original
Summary · why it matters

StockStory identifies Lennar as a risky S&P 500 stock to sell, while naming PTC and AbbVie as promising stocks to watch. Lennar faces declining demand with a 9.2% average backlog drop over two years and an 8.9% annual earnings per share decline over five years, despite revenue growth. PTC shows strength with 21% average billings growth, an 84.7% gross margin, and a 38.7% operating margin. AbbVie benefits from a $62.82 billion revenue base, strong free cash flow, and a 17.5% return on invested capital.

Impact on stocks 3

Consumer Discretionary · 1 stocks
Lennar Corporation
LEN
▼ NegativeDemandrelevance

Lennar faces declining demand with a 9.2% average backlog drop over two years and 8.9% annual EPS decline.

Biotech & Genomic Medicine · 1 stocks
AbbVie Inc
ABBV
▲ PositiveCapitalrelevance

AbbVie is highlighted as promising due to strong financial metrics: $62.82B revenue, high free cash flow, and 17.5% ROIC.

Cloud & Digital Infrastructure · 1 stocks
PTC Inc
PTC
▲ PositiveCapitalrelevance

PTC shows strength with 21% average billings growth, 84.7% gross margin, and 38.7% operating margin.